Literature DB >> 11014932

Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome.

R V Thakker1.   

Abstract

Recent advances in molecular biology have characterised a new class of chloride channels that are referred to as voltage-gated chloride channels (CLCs). To date 9 such CLCs (CLC-1 to CLC-7, CLC-Ka and CLC-Kb which are respectively encoded by the genes CLCN1 to CLCN7, CLCNKa and CLCNKb) have been identified in mammals. Mutations in 2 of these, referred to as CLC-5 and CLC-Kb, have been defined in the hypercalciuric nephrolithiasis disorders of Dent's disease and a form of Bartter's syndrome, respectively. In addition, other forms of Bartter's syndrome have been defined with mutations involving the bumetanide-sensitive sodium-potassium-chloride co-transporter (NKCC2) and the potassium channel ROMK. Finally, mutations of the thiazide-sensitive sodium chloride co-transporter (NCCT) are associated with Gitelman's syndrome, in which hypocalciuria and hypomagnesaemia are notable features. These molecular genetic studies have increased our understanding of the renal tubular mechanisms that regulate mineral homeostasis. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014932     DOI: 10.1159/000020689

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  6 in total

1.  A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.

Authors:  Yuxin Mao; Daniel M Balkin; Roberto Zoncu; Kai S Erdmann; Livia Tomasini; Fenghua Hu; Moonsoo M Jin; Michael E Hodsdon; Pietro De Camilli
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

2.  The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing.

Authors:  Mark Stevenson; Alistair T Pagnamenta; Heather G Mack; Judith Savige; Edoardo Giacopuzzi; Kate E Lines; Jenny C Taylor; Rajesh V Thakker
Journal:  J Endocr Soc       Date:  2022-05-15

Review 3.  Genetic causes of hypercalciuric nephrolithiasis.

Authors:  Michael J Stechman; Nellie Y Loh; Rajesh V Thakker
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

4.  Impaired expression of an organic cation transporter, IMPT1, in a knockout mouse model for kidney stone disease.

Authors:  Eleni G Tzortzaki; Min Yang; Dayna Glass; Li Deng; Andrew P Evan; Sharon B Bledsoe; Peter J Stambrook; Amrik Sahota; Jay A Tischfield
Journal:  Urol Res       Date:  2003-07-11

5.  Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5' UTR end of ClC-5 mRNA in human renal tissue and leukocytes.

Authors:  Monica Forino; Romina Graziotto; Enrica Tosetto; Giovanni Gambaro; Angela D'Angelo; Franca Anglani
Journal:  J Hum Genet       Date:  2003-12-13       Impact factor: 3.172

6.  Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure.

Authors:  Andrew J Smith; Anita A C Reed; Nellie Y Loh; Rajesh V Thakker; Jonathan D Lippiat
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.